These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 620409)
1. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products. Sasaki T; Abiko N; Sugino Y; Nitta K Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans. Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140. Sasaki T; Abiko N; Nitta K; Takasuka N; Sugino Y Eur J Cancer (1965); 1979 Feb; 15(2):211-5. PubMed ID: 436898 [No Abstract] [Full Text] [Related]
4. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Morikawa K; Takeda R; Yamazaki M; Mizuno D Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435 [TBL] [Abstract][Full Text] [Related]
6. A cleavage product of mouse C3 adsorbable to (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140. Matsushita M; Sankawa U; Okuda T; Okada H; Sasaki T Jpn J Exp Med; 1983 Oct; 53(5):219-25. PubMed ID: 6206261 [TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators. Morikawa K; Kamegaya S; Yamazaki M; Mizuno D Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K; Oka T; Morimoto M Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218 [TBL] [Abstract][Full Text] [Related]
9. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids. Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528 [No Abstract] [Full Text] [Related]
10. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Cheung NK; Modak S Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of cell wall beta-1,3/1,6-glucans from Phytophthora species. Kraus J; Blaschek W; Schütz M; Franz G Planta Med; 1992 Feb; 58(1):39-42. PubMed ID: 1620741 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of Hygrophila spinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice. Mazumdar UK; Gupta M; Maiti S; Mukherjee D Indian J Exp Biol; 1997 May; 35(5):473-7. PubMed ID: 9378516 [TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives. Honda S; Sugino H; Asano T; Kakinuma A Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648 [TBL] [Abstract][Full Text] [Related]
14. Molecular mass and antitumor activities of sulfated derivatives of alpha-glucan from Poria cocos mycelia. Lin Y; Zhang L; Chen L; Jin Y; Zeng F; Jin J; Wan B; Cheung PC Int J Biol Macromol; 2004 Oct; 34(5):289-94. PubMed ID: 15556230 [TBL] [Abstract][Full Text] [Related]
15. Influence of various administration routes on the antitumor efficacy ofTT-232, a novel somatostatin analog. Tejeda M; Gaal D; Schwab RE; Pap A; Szúts T; Keri G Anticancer Res; 2000; 20(2A):1023-7. PubMed ID: 10810391 [TBL] [Abstract][Full Text] [Related]
16. Antitumor polysaccharide-induced tumor-regressing factor in the serum of tumor-bearing mice: purification and characterization. Kunimoto T; Baba H; Nitta K J Biol Response Mod; 1986 Jun; 5(3):225-35. PubMed ID: 3723139 [TBL] [Abstract][Full Text] [Related]
17. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124 [TBL] [Abstract][Full Text] [Related]
18. Carcinostatic effect of aliphatic aldehydes and aldehyde dehydrogenase activity in Ehrlich carcinoma, Sarcoma 180, and Yoshida AH 130 hepatoma. Perin A; Sessa A; Ciaranfi E Cancer Res; 1978 Jul; 38(7):2180-4. PubMed ID: 207425 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Suga T; Shiio T; Maeda YY; Chihara G Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]